Access cutting-edge multiple myeloma treatment through this clinical trial at a research site in Hackensack. Study-provided care at no cost to qualified participants.
Access multiple myeloma specialists in Hackensack at no cost
This study follows strict safety protocols and ethical guidelines
All study-related multiple myeloma treatment provided free
The purpose of this study is to assess the safety, tolerability and preliminary effectiveness of CC-92480 (BMS-986348) in novel therapeutic combinations for the treatment of Relapsed or Refractory Multiple Myeloma (RRMM).
Sponsor: Bristol-Myers Squibb
Check if you qualify for this multiple myeloma clinical trial in Hackensack, NJ
If you're searching for multiple myeloma treatment options in Hackensack, NJ, this clinical trial may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Hackensack research site is actively enrolling participants for this clinical trial. You'll receive care from experienced multiple myeloma specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.